Faeth Therapeutics grants 94,000 inducement stock options at USD 34.52 per share

• Faeth Therapeutics granted new-hire stock options covering 94,000 shares, effective Aug. 25, 2026, under its 2026 Inducement Plan.
• Options carry a $34.52 exercise price, matching the closing share price on the grant date.
• 25% vests on the first anniversary of each employee’s start date; the remainder vests in 36 monthly installments, subject to continued service.
• Options expire 10 years from the grant date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faeth Therapeutics Inc published the original content used to generate this news brief via Business Wire (Ref. ID: 202608280730BIZWIRE_USPR_____20260828_BW329645) on August 28, 2026, and is solely responsible for the information contained therein.